8-K: Nexalin Technology Faces Nasdaq Delisting Threat

Nexalin Technology, Inc. has received a notice from Nasdaq indicating it no longer meets the minimum stockholders equity requirement for continued listing, adding to previous concerns about bid price.

Summary

• Nexalin Technology, Inc. received a letter on August 14, 2026, from Nasdaq stating it no longer meets the minimum stockholders equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market.
• The company's stockholders equity was reported as $1,519,423 in its Form 10-Q for the period ended June 30, 2026.
• This deficiency is in addition to a previous delisting notice received on July 24, 2026, regarding the minimum bid price requirement.
• The company has requested a hearing before a Nasdaq Hearing Panel, scheduled for September 1, 2026, to appeal both deficiencies.
• There is no assurance of success in the appeal, and a delisting could materially adversely affect the liquidity and market price of the common stock and the company's ability to raise capital.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative development due to the company's failure to meet Nasdaq's continued listing requirements, increasing the risk of delisting.

Negatives

• The company no longer satisfies the minimum stockholders equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market.
• The company's stockholders equity was $1,519,423 as of June 30, 2026.
• The company also faces non-compliance with the minimum bid price requirement.
• The Nasdaq Hearing Panel has broad discretionary authority and could delist the securities despite compliance efforts.

Risks

• Potential delisting from The Nasdaq Capital Market if the appeal is unsuccessful.
• Material adverse effect on the liquidity and market price of the company's common stock if delisted.
• Impaired ability to raise capital if delisted.
• The Nasdaq Hearing Panel may consider factors beyond the specific deficiencies, such as reverse stock split history, financial condition, and capital-raising activities.

Future Outlook

The company intends to present its plan to regain compliance with Nasdaq's minimum bid price and stockholders equity requirements at the upcoming hearing. However, there is no assurance of success, and the outcome is subject to the Nasdaq Hearing Panel's broad discretionary authority.

Management Comments

• The Company intends to present its views with respect to the Stockholders Equity Deficiency at the Hearing, together with its plan to evidence compliance with the Minimum Bid Price Requirement and the Stockholders Equity Requirement.
• There can be no assurance that the Company will be successful in its appeal before the Panel, that the Panel will grant the Company any additional period within which to regain compliance with the Stockholders Equity Requirement, the Minimum Bid Price Requirement, or any other applicable Nasdaq continued listing standard, or that, if any such period is granted, the Company will be able to evidence compliance with all applicable Nasdaq continued listing requirements within that period.

Industry Context

StockSavvy.ai notes that maintaining listing on major exchanges like Nasdaq is critical for investor confidence and access to capital. Failure to meet continued listing standards, particularly equity and bid price requirements, often signals financial distress and can significantly impact a company's valuation and operational flexibility.

Stakeholder Impact

• Shareholders: Potential decrease in stock liquidity and market price, and increased risk of holding a delisted security.
• Creditors/Lenders: Increased risk due to potential inability of the company to raise capital and potential impact on financial stability.
• Employees: Potential impact on morale and job security if the company faces significant financial distress.

Next Steps

• Present views and plan for compliance with Stockholders Equity Requirement and Minimum Bid Price Requirement at the Nasdaq Hearing Panel on September 1, 2026.
• Await determination from the Nasdaq Hearing Panel regarding continued listing on The Nasdaq Capital Market.

Key Dates

Recommendation

The company is facing delisting from Nasdaq due to failure to meet both stockholders equity and minimum bid price requirements. This significantly increases risk, impairs capital raising ability, and is likely to negatively impact stock price and liquidity, making it a sell.

Keywords

Nasdaq listing requirements, Stockholders equity, Delisting, Bid price deficiency, Nasdaq Hearing Panel, Continued listing standards, Capital raising